Author

Benjamin T. Marchello

Observed names: B Marchello, B. T. Marchello, B.T. Marchello, Benjamin Marchello, Marchello, Benjamin T

Observed institutions: Mayo Clinic, Kaiser Permanente, University of Pittsburgh, Wayne State University, University of Florida Health, Massachusetts General Hospital, The Barbara Ann Karmanos Cancer Institute, Montana Cancer Consortium, St. Luke's Hospital, NRG Oncology, NSABP Foundation, Kaiser Permanente Northern California, Billings Clinic

OpenAlex ID: A5084942272

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

2014 · Michael J. O'Connell, Linda H. Colangelo, et al. · Journal of Clinical Oncology · 439

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

2015 · Carmen J. Allegra, Greg Yothers, et al. · JNCI Journal of the National Cancer Institute · 326

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer

2023 · Deborah Schrag, Hajime Uno, et al. · JAMA · 146

Comparative Effectiveness of Sphincter-Sparing Surgery Versus Abdominoperineal Resection in Rectal Cancer

2014 · Marcia M. Russell, Patricia A. Ganz, et al. · Annals of Surgery · 73

Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)

2009 · Andrea L. Cheville, Jeff A. Sloan, et al. · Supportive Care in Cancer · 63

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

2015 · H.H. Yoon, N.R. Foster, et al. · Annals of Oncology · 54

Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma

2013 · Roxana S. Dronca, Jacob B. Allred, et al. · American Journal of Clinical Oncology · 43

Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2

2008 · Paul J. Hesketh, Kari Chansky, et al. · Journal of Thoracic Oncology · 39

Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial.

2012 · Robert R. McWilliams, Michelle R. Mahoney, et al. · Journal of Clinical Oncology · 10

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network

2024 · Nicole L. Stout, Daniel Nikcevich, et al. · Journal of Clinical Oncology · 6

A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)

2019 · Kaushal Parikh, Sumithra J. Mandrekar, et al. · The Oncologist · 5

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer

2026 · P.A. Francis, P.A. Francis, et al. · Annals of Oncology · 4

Alliance A091102: Phase II study of MLN8237 (alisertib) in advanced/metastatic sarcoma.

2013 · Mark Andrew Dickson, Michelle R. Mahoney, et al. · Journal of Clinical Oncology · 3

N0675: NCCTG phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma (MM).

2010 · R. S. Dronca, D. G. Perez, et al. · Journal of Clinical Oncology · 3

Comparative effectiveness of sphincter-sparing surgery (SSS) versus abdomino-perineal resection (APR) in rectal cancer: Patient-reported outcomes (PROs) from NSABP R-04.

2012 · Patricia A. Ganz, Samia H. Lopa, et al. · Journal of Clinical Oncology · 1

Evaluation of the impact of a CCOP program in a low population density area of Montana.

1987 · N Hammond, B Marchello, et al. · PubMed · 1

Use of gene expression profiling to identify responsive patients treated with carboplatin (Carb), paclitaxel (Pac), and everolimus as first-line treatment for cancer of unknown primary (CUP): NCCTG N0871 (Alliance).

2013 · Matthew P. Goetz, Nathan R. Foster, et al. · Journal of Clinical Oncology

Works count: 19

Citation count: 1,216

H-index: 9

I10-index: 9